Microarray-based survey of CpG islands identifies concurrent hyper- and hypomethylation patterns in tissues derived from patients with breast cancer

Genes Chromosomes and Cancer

Volumn 45, Issue 7, 2006, Pages 656-667

  Piotrowski, Arkadiusz ^a,b   Benetkiewicz, Magdalena ^a   Menzel, Uwe ^a   Díaz De Ståhl, Teresita ^a   Mantripragada, Kiran ^a   Grigelionis, Gintautas ^a   Buckley, Patrick G ^a   Jankowski, Michał ^c   Hoffman, Jacek ^c   Bała, Dariusz ^c   Śrutek, Ewa ^c   Laskowski, Ryszard ^c   Zegarski, Wojciech ^c   Dumanski, Jan P ^a,d  

^a UPPSALA UNIVERSITY   (Sweden)

^b MEDICAL UNIVERSITY OF GDANSK   (Poland)

^c NICOLAUS COPERNICUS UNIVERSITY   (Poland)

^d UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BISULFITE; METALLOTHIONEIN;

ARTICLE; BREAST CANCER; CANCER PATIENT; COL9A1 GENE; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; EPIGENETICS; FEMALE; FLJ45983 GENE; GENE; GENE DISRUPTION; GENE LOSS; GENE SEQUENCE; GENE STRUCTURE; GENETIC CONSERVATION; GENETIC HETEROGENEITY; GENOME ANALYSIS; HOMEOSTASIS; HOXA5 GENE; HUMAN; HUMAN CELL; HUMAN TISSUE; HYBRIDIZATION; MICROARRAY ANALYSIS; MT1A GENE; MT1J GENE; MULTIGENE FAMILY; PRIORITY JOURNAL; PROMOTER REGION;

BREAST NEOPLASMS; CPG ISLANDS; DNA METHYLATION; DNA, NEOPLASM; FEMALE; HUMANS; MALE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS;

EID: 33646551521     PISSN: 10452257     EISSN: 10982264     Source Type: Journal    
DOI: 10.1002/gcc.20331     Document Type: Article

References (44)

1. Bae YK, Brown A, Garrett E, Bornman D, Fackler MJ, Sukumar S, Herman JG, Gabrielson E. 2004. Hypermethylation in histologically distinct classes of breast cancer. Clin Cancer Res 10:5998-6005.
2. Buckley P, Mantripragada K, Díaz de Ståhl T, Piotrowski A, Hansson C, Kiss H, Vetrie D, Ernberg I, Nordenskjöld M, Bolund L, Sainio M, Rouleau G, Niimura M, Wallace A, Evans D, Grigelionis G, Menzel U, Dumanski J. 2005. Identification of genetic aberrations on chromosome 22 outside the NF2 locus in schwannomatosis and neurofibromatosis type 2. Hum Mutat 26:540-549.
3. Buckley PG, Mantripragada KK, Benetkiewicz M, Tapia-Paez I, Diaz De Stahl T, Rosenquist M, Ali H, Jarbo C, De Bustos C, Hirvela C, Sinder Wilen B, Fransson I, Thyr C, Johnsson BI, Bruder CE, Menzel U, Hergersberg M, Mandahl N, Blennow E, Wedell A, Beare DM, Collins JE, Dunham I, Albertson D, Pinkel D, Bastian BC, Faruqi AF, Lasken RS, Ichimura K, Collins VP, Dumanski JP. 2002. A full-coverage, high-resolution human chromosome 22 genomic microarray for clinical and research applications. Hum Mol Genet 11:3221-3229.
4. Chalitchagorn K, Shuangshoti S, Hourpai N, Kongruttanachok N, Tangkijvanich P, Thong-ngam D, Voravud N, Sriuranpong V, Mutirangura A. 2004. Distinctive pattern of LINE-1 methylation level in normal tissues and the association with carcinogenesis. Oncogene 23:8841-8846.
5. Chen H, Chung S, Sukumar S. 2004. HOXA5-induced apoptosis in breast cancer cells is mediated by caspases 2 and 8. Mol Cell Biol 24:924-935.
6. Ching TT, Maunakea AK, Jun P, Hong C, Zardo G, Pinkel D, Albertson DG, Fridlyand J, Mao JH, Shehors K, Weiss WA, Costello JF. 2005. Epigenome analyses using BAC microarrays identify evolutionary conservation of tissue-specific methylation of SHANK3. Nat Genet 37:645-651.
7. Colella S, Shen L, Baggerly KA, Issa JP, Krahe R. 2003. Sensitive and quantitative universal Pyrosequencing mechylation analysis of CpG sites. Biotechniques 35:146-150.
8. Cross SH, Charlton JA, Nan X, Bird AP. 1994. Purification of CpG islands using a methylated DNA binding column. Nat Genet 6:236-244.
9. de Bustos C, Diaz de Ståhl T, Piotrowski A, Mantripragada K, Buckley P, Darai E, Hansson C, Grigelionis G, Menzel U, Dumanski J. Analysis of copy number variation in normal human population within a region containing complex segmental duplications on 22q11 using high resolution array-CGH. Genomics (in press).
10. Dhami P, Coffey AJ, Abbs S, Vermeesch JR, Dumanski JP, Woodward KJ, Andrews RM, Langford C, Vetrie D. 2005. Exon array CGH: Detection of copy-number changes at the resolution of individual exons in the human genome. Am J Hum Genet 76:750-762.
11. Esteller M. 2002. CpG island hypermethylation and tumor suppressor genes: A booming present, a brighter future. Oncogene 21:5427-5440.
12. Esteller M. 2005. Dormant hypermethylated tumour suppressor genes: Questions and answers. J Pathol 205:172-180.
13. Esteller M, Corn PG, Baylin SB, Herman JG. 2001. A gene hypermethylation profile of human cancer. Cancer Res 61:3225-3229.
14. Feinberg AR 2004. The epigenetics of cancer etiology. Semin Cancer Biol 14:427-432.
15. Gardiner-Garden M, Frommer M. 1987. CpG islands in vertebrate genomes. J Mol Biol 196:261-282.
16. Goll MG, Bestor TH. 2004. Eukaryotic cytosine methyltransferases. Annu Rev Biochem 2005; 74:481-514.
17. Grunau C, Sanchez C, Ehrlich M, van der Bruggen P, Hindermann W, Rodriguez C, Krieger S, Dubeau L, Fiala E, De Sario A. 2005. Frequent DNA hypomethylation of human juxtacentromeric BAGE loci in cancer. Genes Chromosomes Cancer 43:11-24.
18. Guo Y, Pakneshan P, Gladu J, Slack A, Szyf M, Rabbani SA. 2002. Regulation of DNA methylation in human breast cancer. Effect on the urokinase-type plasminogen activator gene production and tumor invasion. J Biol Chem 277:41571-41579.
19. Gupta A, Godwin AK, Vanderveer L, Lu A, Liu J. 2003. Hypomethylation of the synuclein gamma gene CpG island promotes its aberrant expression in breast carcinoma and ovarian carcinoma. Cancer Res 63:664-673.
20. Huang TH, Perry MR, Laux DE. 1999. Methylation profiling of CpG islands in human breast cancer cells. Hum Mol Genet 8:459-470.
21. Jackson K, Yu MC, Arakawa K, Fiala E, Youn B, Fiegl H, Muller-Holzner E, Widschwendter M, Ehrlich M. 2004. DNA hypomethylation is prevalent even in low-grade breast cancers. Cancer Biol Ther 3:1225-1231.
22. Jin R, Huang J, Tan PH, Bay BH. 2004. Clinicopathological significance of metallothioneins in breast cancer. Pathol Oncol Res 10:74-79.
23. Larochelle C, Tremblay M, Bernier D, Aubin J, Jeannotte L. 1999. Multiple cis-acting regulatory regions are required for restricted spatio-temporal Hoxa5 gene expression. Dev Dyn 214:127-140.
24. Lim JH, Kim SP, Gabrielson E, Park YB, Park JW, Kwon TK. 2005. Activation of human cancer/testis antigen gene, XAGE-1, in tumor cells is correlated with CpG island hypomethylation. Int J Cancer 116:200-206.
25. Mantripragada KK, Buckley PG, Jarbo C, Menzel U, Dumanski JP. 2003. Development of NF2 gene specific, strictly sequence defined diagnostic microarray for deletion detection. J Mol Med 81:443-451.
26. Mantripragada KK, Tapia-Paez I, Blennow E, Nilsson P, Wedell A, Dumanski JP. 2004. DNA copy-number analysis of the 22q11 deletion-syndrome region using array-CGH with genomic and PCR-based targets. Int J Mol Med 13:273-279.
27. Mantripragada KK, Thuresson AC, Piotrowski A, Diaz de Stahl T, Menzel U, Grigelionis G, Ferner RE, Griffiths S, Bolund L, Mautner V, Nordling M, Legius E, Vetrie D, Dahl N, Messiaen L, Upadhyaya M, Bruder CE, Dumanski JR 2005. Identification of novel deletion breakpoints bordered by segmental duplications in the NFl locus using high-resolution array-CGH. J Med Genet 43:28-38.
28. Moreau J, Jeannotte L. 2002. Sequence analysis of a Hoxa4-Hoxa5 intergenic region including shared regulatory elements. DNA Seq 13:203-209.
29. Narayan A, Ji W, Zhang XY, Macrogi A, Graff JR, Baylin SB, Ehrlich M. 1998. Hypomethyladon of pericenuomedc DNA in breast adenocarcinomas. Int J Cancer 77:833-838.
30. Raman V, Mattensen SA, Reisman D, Evron E, Odenwald WF, Jaffee E, Marks J, Sukumar S. 2000. Compromised HOXA5 function can limit p53 expression in human breast tumours. Nature 405:974-978.
31. Ramaswamy S, Ross KN, Lander ES, Golub TR. 2003. A molecular signature of metastasis in primary solid tumors. Nat Genet 33:49-54.
32. Sambrook J, Russell D. 2001. Molecular Cloning: A Laboratory Manual, 3rd ed. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press.
33. Stasinopoulos IA, Mironchik Y, Raman A, Wildes F, Winnard P, Jr., Raman V. 2005. HOXA5-twist interaction alters p53 homeostasis in breast cancer cells. J Biol Chem 280:2294-2299.
34. Szyf M, Pakneshan P, Rabbani SA. 2004. DNA methylation and breast cancer. Biochem Pharmacol 68:1187-1197.
35. Takai D, Jones PA. 2002. Comprehensive analysis of CpG islands in human chromosomes 21 and 22. Proc Natl Acad Sci USA 99:3740-3745.
36. Theocharis SE, Margeli AP, Klijanienko JT, Kouraklis GP. 2004. Metallothionein expression in human neoplasia. Histopathology 45:103-118.
37. Thoraval D, Asakawa J, Wimmer K, Kuick R, Lamb B, Richardson B, Ambros P, Glover T, Hanash S. 1996. Demethylation of repetitive DNA sequences in neuroblastoma. Genes Chromosomes Cancer 17:234-244.
38. Uhlmann K, Brinckmann A, Toliat MR, Ritter H, Nurnberg P. 2002. Evaluation of a potential epigenetic biomarker by quantitative methyl-single nucleotide polymorphism analysis. Electrophoresis 23:4072-4079.
39. Ushijima T, Okochi-Takada E. 2005. Aberrant methylations in cancer cells: Where do they come from? Cancer Sci 96:206-211.
40. van Noesel MM, van Bezouw S, Voute PA, Herman JG, Pieters R, Versteeg R. 2003. Clustering of hypermethylated genes in neuroblastoma. Genes Chromosomes Cancer 38:226-233.
41. Weber M, Davies JJ, Wittig D, Oakeley EJ, Haase M, Lam WL, Schubeler D. 2005. Chromosome-wide and promoter-specific analyses identify sites of differential DNA methylation in normal and transformed human cells. Nat Genet 37:853-862.
42. Wilkins JF. 2005. Genomic imprinting and methylation: Epigenetic canalization and conflict. Trends Genet 21:356-365.
43. Van PS, Efferth T, Chen HL, Lin J, Rodel F, Fuzesi L, Huang TH. 2002. Use of CpG island microarrays to identify colorectal tumors with a high degree of concurrent methylation. Methods 27:162-169.
44. Zhang P, Jimenez SA, Stokes DG. 2003. Regulation of human COL9A1 gene expression. Activation of the proximal promoter region by SOX9. J Biol Chem 278:117-123.